Jr. A. Anthony Florence

Affiliations

  • at Korro Bio Inc. (KRRO), 2024-04-24
  • at Neuehealth Inc. (NEUE), 2024-04-10
  • Large Shareholder at Synlogic Inc. (SYBX), 2023-10-06
  • Large Shareholder at Berkshire Grey Inc. (BGRY), 2023-07-24
  • Large Shareholder at Savara Inc (SVRA), 2023-07-19
  • Large Shareholder at Mirum Pharmaceuticals Inc. (MIRM), 2023-06-15
  • Large Shareholder at Arcellx Inc. (ACLX), 2022-12-22
  • Large Shareholder at Akouos Inc. (AKUS), 2022-12-02
  • Large Shareholder at Ionq Inc. (IONQ), 2022-11-18
  • Large Shareholder at Aveo Pharmaceuticals Inc. (AVEO), 2022-10-21
  • Large Shareholder at Zerofox Holdings Inc. (ZFOX), 2022-08-05
  • Large Shareholder at Senti Biosciences Inc.\ (SNTI), 2022-06-15
  • Large Shareholder at Genocea Biosciences Inc. (GNCA), 2022-05-26
  • Director at Robinhood Markets Inc. (HOOD), 2022-05-04
  • Large Shareholder at Trevi Therapeutics Inc. (TRVI), 2022-04-13
  • Large Shareholder at Imara Inc. (IMRA), 2022-04-07
  • Large Shareholder, Director at Casper Sleep Inc. (CSPR), 2022-01-26
  • Large Shareholder at Metacrine Inc. (MTCR), 2021-12-27
  • Large Shareholder at Monte Rosa Therapeutics Inc. (GLUE), 2021-06-30
  • Large Shareholder at Desktop Metal Inc. (DM), 2021-06-10
  • Large Shareholder at Eargo Inc. (EAR), 2021-05-26
  • Large Shareholder at Reneo Pharmaceuticals Inc. (RPHM), 2021-04-15
  • Large Shareholder at Marker Therapeutics Inc. (MRKR), 2021-03-18
  • Other at Regulus Therapeutics Inc. (RGLS), 2021-03-17
  • Large Shareholder at Verona Pharma Plc (VRNA), 2021-01-05
  • Large Shareholder at Mersana Therapeutics Inc. (MRSN), 2020-09-16
  • Large Shareholder at Inozyme Pharma Inc. (INZY), 2020-07-28
  • Large Shareholder at Annexon Inc. (ANNX), 2020-07-23
  • Large Shareholder at Nkarta Inc. (NKTK), 2020-07-16
  • Large Shareholder at Surface Oncology Inc. (SURF), 2020-05-22
  • Large Shareholder at Champions Oncology Inc. (CSBR), 2020-03-10
  • Large Shareholder at Black Diamond Therapeutics Inc. (BDTX), 2020-01-30
  • Large Shareholder at Adaptimmune Therapeutics Plc (ADAP), 2020-01-28
  • Large Shareholder at Ardelyx Inc. (ARDX), 2019-12-09
  • Large Shareholder at Galera Therapeutics Inc. (GRTX), 2019-11-12
  • Large Shareholder at Oyster Point Pharma Inc. (OYST), 2019-11-04
  • Large Shareholder at Nightstar Therapeutics Plc (NITE), 2019-06-07
  • Large Shareholder at Millendo Therapeutics Inc. (MLND), 2018-12-12
  • Large Shareholder at Mulesoft Inc (MULE), 2018-05-09
  • Large Shareholder at Tracon Pharmaceuticals Inc. (TCON), 2018-03-27
  • Large Shareholder at Cascadian Therapeutics Inc. (CASC), 2018-03-13
  • Large Shareholder at Arca Biopharma Inc. (ABIO), 2018-02-27
  • Large Shareholder at Appian Corp (APPN), 2018-02-15
  • Large Shareholder at Strongbridge Biopharma Plc (SBBP), 2018-01-09
  • Large Shareholder at Arsanis Inc. (ASNS), 2017-11-20
  • Large Shareholder at Achaogen Inc (AKAO), 2016-12-19
  • Large Shareholder at Interleukin Genetics Inc (ILIU), 2016-08-02
  • Large Shareholder at Cerecor Inc. (CERC), 2015-10-20
  • Director at Cvent Inc (CVT), 2015-06-11
  • Large Shareholder at Loxo Oncology Inc. (LOXO), 2014-08-06
  • Director at Care.com Inc (CRCM), 2014-01-23
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
KRRO $56.00 17,857 1,090,793 2024-04-22 Filing
SVRA $3.00 333,333 Large Shareholder 24,471,264 2023-07-17 Filing
TRVI $1.90 948,948 Large Shareholder 948,948 2022-04-11 Filing
TRVI $1.90 2,631,578 Large Shareholder 10,421,428 2022-04-11 Filing
TRVI $0.00 1,851,852 Large Shareholder 7,789,850 2021-10-18 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ACLX $30.74 179 Large Shareholder 0 2022-12-21 Filing
GNCA $0.08 4,445,093 Large Shareholder 0 2022-05-25 Filing
GNCA $0.07 5,931,843 Large Shareholder 4,445,093 2022-05-24 Filing
HOOD $10.06 1,952 Director 0 2022-05-03 Filing
HOOD $14.22 2,082 Director 0 2022-01-31 Filing